Paid Clinical Trials in Huntington Beach, CA
As of June 2026, 86 paid clinical trials are recruiting in Huntington Beach, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Huntington Beach offers studies at sites including City of Hope Seacliff for conditions such as Asthma, Atrial Fibrillation (AF), Geographic Atrophy Secondary to Age-related Macular Degeneration, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Huntington Beach
Trials by drug in Huntington Beach
Filter results
84 clinical trials
↓ Download CSVAn Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
About research studies in Huntington Beach
Huntington Beach has approximately 86 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in Huntington Beach
Researchers run research studies in Huntington Beach, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| City of Hope Seacliff | Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma, Advanced Rectal Adenocarcinoma | 12 |
| Marvel Clinical Research | Atopic Dermatitis, Atopic Dermatitis (AD), Diabetic Peripheral Neuropathic Pain | 9 |
| Retina Associates of Southern California | Diabetic Macular Edema, Dry Age-related Macular Degeneration, Geographic Atrophy | 6 |
| Care Access - Huntington Beach | Alzheimer Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Dementia | 4 |
| Keck Medicine of USC Huntington Beach | Malignant Solid Neoplasm, Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Malignant Neoplasm in the Liver | 4 |
| Newport Huntington Medical Group | Arthritis, Psoriatic, Overweight or Obesity, Psoriatic Arthritis | 3 |
| AME Clinical Research | Diabetes Mellitus, Type 1, Diabetic Kidney Disease (DKD) | 2 |
| City of Hope | EGFR/HER2 Exon 20 Insertion Mutation, NSCLC, Non-Small Cell Lung Cancer | 2 |
| National Institute of California Heart and Vein Specialists | Atrial Fibrillation (AF) | 2 |
| National Institute of Clinical Research | Heart, Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction | 2 |
| Salehi Retina Institute Inc. | Diabetic Retinopathy, Epiretinal Membrane | 2 |
| City Of Hope - Seacliff | Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer | 2 |
| Newport Huntington Medical Group | Rheumatoid Arthritis, Psoriatic Arthritis | 2 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Allergy and Asthma Specialists Group | Chronic Spontaneous Urticaria (CSU) | 1 |
| Allergy and Asthma Specialists Medical Group | Perennial Allergic Rhinitis (PAR) | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Azul Vision, INC | Persistent Corneal Epithelial Defect | 1 |
| Baxis | Bacterial Conjunctivitis | 1 |
| California Aesthetic Center | Capsular Contracture Associated With Breast Implant, Capsular Contracture Grade III, Capsular Contracture Grade IV | 1 |
| California Heart Specialist | Heart Failure, Obesity | 1 |
| Care Access Research - Huntington Beach | Systemic Lupus Erythematosus (SLE) | 1 |
| City of Hope at Seacliff | Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
Active & Upcoming Studies in Huntington Beach (2026)
Recruiting trials in Huntington Beach grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (17 active studies)
- Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 · Phase 2 · City of Hope Medical Center
- Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial · Phase 2 · City of Hope Medical Center
Eye & vision (11 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Cardiovascular (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable · Phase 3 · Regeneron Pharmaceuticals
Diabetes & metabolic (6 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight · Phase 3 · Eli Lilly and Company
Neurology & pain (2 active studies)
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
HIV / STI (1 active study)
Common conditions studied in Huntington Beach
- Asthma (4 active studies). Asthma research tests biologic therapies targeting IL-4, IL-5, and TSLP pathways for moderate-to-severe and eosinophilic disease.
- Atrial Fibrillation (AF) (3 active studies). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
- Geographic Atrophy Secondary to Age-related Macular Degeneration (3 active studies). Recruiting Geographic Atrophy Secondary to Age-related Macular Degeneration studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (3 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Obesity (3 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Atopic Dermatitis (2 active studies). Atopic dermatitis studies test IL-13 inhibitors, JAK inhibitors, and next-generation topical therapies for moderate-to-severe eczema.
Leading research sponsors in Huntington Beach
- City of Hope Medical Center
- Eli Lilly and Company
- AbbVie
- Regeneron Pharmaceuticals
- SWOG Cancer Research Network
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Huntington Beach. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Huntington Beach
Hipa.ai aggregates every recruiting study in Huntington Beach from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Huntington Beach?
There are approximately 86 recruiting clinical trials in Huntington Beach, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Huntington Beach pay participants?
Most recruiting trials in Huntington Beach compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Huntington Beach?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Huntington Beach?
The most common conditions under active study in Huntington Beach include Asthma (4), Atrial Fibrillation (AF) (3), Geographic Atrophy Secondary to Age-related Macular Degeneration (3), Heart Failure (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Huntington Beach?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Huntington Beach on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Huntington Beach?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Huntington Beach?
Recruiting research sites in Huntington Beach include City of Hope Seacliff, Marvel Clinical Research, Retina Associates of Southern California, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Huntington Beach right now?
The largest active categories in Huntington Beach are Cancer & tumors (17), Eye & vision (11), Cardiovascular (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.